TALS Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own TALS shares is N/A, representing N/A of the company's common stock.

WALLEYE CAPITAL LLC, in the last quarter, reduced its stake in TALS by -13.83% restricting it's holding to 262.47 thousand shares of worth nearly $737.54K. RHUMBLINE ADVISERS also lessened -66.73% of the TALS shares from its portfolio, reducing its holding to 1.16 thousand shares of worth $3.27K. JPMORGAN CHASE & CO also shunned TALS shares holding by -14.32% last quarter which brought its holding to 388.13 thousand shares worth $1.09M.

As per its latest 13F filing, BRIDGEWAY CAPITAL MANAGEMENT, LLC increased its stake in TALS by 101.72% in the last quarter. The institutional holder raised its holding to 301.18 thousand shares having worth more than $846.30K. DIMENSIONAL FUND ADVISORS LP also added 208.32% more shares of TALS to its portfolio, raising its holding to 272.77 thousand shares of worth $766.49K. TOWER RESEARCH CAPITAL LLC (TRC) also increased its TALS shares holding by 100% which brought its holding to 962 shares worth $2.70K.

The insider with the most stakes in TALS is Ildstad Suzanne , director at the company. Additionally, TALS stock is highly held by Agarwala Sandip and 10 percent owner Longitude Capital Partners III, LLC among others.

Company executives, directors, and other insiders own N/A percent of Talaris Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which TALS insiders have sold stock, totaling 0 shares. Insiders that have sold shares include ILDSTAD SUZANNE.

There have been 0 transaction(s) during the past 6-months in which Talaris Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 Talaris Therapeutics, Inc. shares are held by insiders, which represents about N/A of TALS stock.

TALS director, Ildstad Suzanne holds the largest portfolio of the company's shares. TALS shares owned by Ildstad total nearly 3.77 million.

BLACKSTONE INC. is the largest institutional owner in TALS which holds 8.09 million shares worth $22.73M or 19.18% of the total TALS shares outstanding followed by BRIDGEWAY CAPITAL MANAGEMENT, LLC with ownership of 301.18 thousand shares representing 0.71% of the TALS ownership. DIMENSIONAL FUND ADVISORS LP is the third largest stakeholder with 272.77 thousand shares or 0.65% of the ownership worth more than $766.49K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the TALS is concerned, it is a stock which is optionable.

Number of TALS shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, N/A shares of TALS are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, TALS has N/A shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for TALS is N/A.